GeneTether Therapeutics, Inc. (TSE:GTTX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
GeneTether Therapeutics Inc. has successfully secured shareholder approval for a significant licensing agreement with EGB Ventures for STS-201, a promising cancer treatment. This agreement, along with a fully subscribed private placement raising C$500,000, marks a key milestone for the company’s strategic growth. The funds will bolster GeneTether’s research and development efforts.
For further insights into TSE:GTTX stock, check out TipRanks’ Stock Analysis page.
